Difference between revisions of "DZI20-210-Case-1"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Added status template) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 12: | Line 12: | ||
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. | IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. | ||
|reasonCode=70 yo with 3 week history of hemorrhagic tumors | |reasonCode=70 yo with 3 week history of hemorrhagic tumors | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=VN048 |
|authoredOn=October 21, 2020 02:16:00 PM | |authoredOn=October 21, 2020 02:16:00 PM | ||
|requester=Vn048 | |requester=Vn048 | ||
|sequence=1 | |sequence=1 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
| Line 30: | Line 31: | ||
|subject=Z0FBQUFBQmZrRVV6NGxsTGZmc1FyOUpBRzhIbkNIdHZDbVhwN1ZWQnNFMnE4ZmFWTHQ0TDliLXZsU0Q0U2hyWjA4LWl2RTJSN1NhZnFaSWZpaF9VT09rWGtIamlYVW85aWc9PQ | |subject=Z0FBQUFBQmZrRVV6NGxsTGZmc1FyOUpBRzhIbkNIdHZDbVhwN1ZWQnNFMnE4ZmFWTHQ0TDliLXZsU0Q0U2hyWjA4LWl2RTJSN1NhZnFaSWZpaF9VT09rWGtIamlYVW85aWc9PQ | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Vn048 | ||
| + | |authoredOn=October 21, 2020 02:16:00 PM | ||
}} | }} | ||
Latest revision as of 14:01, December 9, 2024
